30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

GRI Bio Inc (GRI)

Track

Stock chart
Ticker: GRI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kelly Leanne M.
Chief Financial Officer
1 purchase — total 6,153 USD
Buy 4 Jun 2021
Value US$925,057.09 | Price 193.11 | Shares 2,907
Buy 3 Jun 2021
Value US$4,554,210.43 | Price 480.54 | Shares 9,840
Buy 2 Jun 2021
Value US$14,628.00 | Price 4.00 | Shares 3,657
Buy 12 Feb 2021
Value US$8,000.00 | Price 8.00 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-04 2021-06-04 B Purchase
3.7
Kelly Leanne M.

Chief Financial Officer

Officer
2,907 +7.6%
193.11
US$925,057 		2,907 +7.6% 193.11 US$925,057
2021-06-04 2021-06-03 B Purchase
3.7
Kelly Leanne M.

Chief Financial Officer

Officer
9,840 -19.9%
480.54
US$4,554,210 		9,840 -19.9% 480.54 US$4,554,210
2021-06-04 2021-06-02 B Purchase
3.7
Kelly Leanne M.

Chief Financial Officer

Officer
14,590 -22.7%
253.89
US$4,524,590 		14,590 -22.7% 253.89 US$4,524,590
2021-02-12 2021-02-12 B Purchase
0.5
Baker David Charles

Chief Executive Officer

Executive Director
1,000 +12.8%
8.00
US$8,000 		1,000 +12.8% 8.00 US$8,000
Explore more

More insider trading research around GRI Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America